Academic Journal

The Impact of Denoising Approaches on the Relationship Between Alzheimer's Disease Diagnostic Status and Network Topology Measures.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: The Impact of Denoising Approaches on the Relationship Between Alzheimer's Disease Diagnostic Status and Network Topology Measures.
Συγγραφείς: Blujus JK; Department of Cognitive and Psychological Sciences, Brown University, Providence, Rhode Island, USA., Oh H; Department of Cognitive and Psychological Sciences, Brown University, Providence, Rhode Island, USA.; Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island, USA.; Carney Institute for Brain Science, Brown University, Providence, Rhode Island, USA.
Συλλογικό Έργο: Alzheimer's Disease Neuroimaging Initiative
Πηγή: Human brain mapping [Hum Brain Mapp] 2026 Aug; Vol. 47 (11), pp. e70622.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Wiley Country of Publication: United States NLM ID: 9419065 Publication Model: Print Cited Medium: Internet ISSN: 1097-0193 (Electronic) Linking ISSN: 10659471 NLM ISO Abbreviation: Hum Brain Mapp Subsets: MEDLINE
Imprint Name(s): Publication: New York : Wiley
Original Publication: New York : Wiley-Liss, c1993-
Ιατρικοί όροι (MeSH): Alzheimer Disease*/diagnostic imaging , Alzheimer Disease*/physiopathology , Magnetic Resonance Imaging*/methods , Magnetic Resonance Imaging*/standards , Cognitive Dysfunction*/diagnostic imaging , Cognitive Dysfunction*/physiopathology , Brain*/diagnostic imaging , Brain*/physiopathology , Nerve Net*/diagnostic imaging , Nerve Net*/physiopathology , Image Processing, Computer-Assisted*/methods , Image Processing, Computer-Assisted*/standards , Connectome*/methods , Connectome*/standards, Humans ; Female ; Male ; Aged ; Aged, 80 and over ; Artifacts
Περίληψη: Graph theory provides a promising technique to investigate Alzheimer's disease (AD)-related alterations in brain network properties. However, there are discrepancies in the reported disruptions that occur to network topology across the AD continuum. In this study, we examined whether diagnostic group differences in graph metrics are attributed to differences in denoising approach used in fMRI processing. Resting state data from 60 cognitively normal (CN), 55 Mild Cognitive Impairment (MCI), and 38 AD participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were denoised using 11 pipelines including combinations of confound regression (head motion parameters, white matter [WM], cerebrospinal fluid [CSF], global signal), volume censoring (scrubbing, spike regression), and component-based noise removal (Independent Component Analysis-based Automatic Removal of Motion Artifacts [ICA-AROMA], anatomical and temporal component correction). Graph metrics representing network segregation (clustering coefficient, modularity, local efficiency), network integration (largest connected component, path length, global efficiency), and small-worldness were calculated. The results revealed that diagnostic group differences in modularity and local efficiency were dependent on denoising approach, especially in high-parameter regression models in combination with censoring methods (36 parameters and spike regressor or volume censoring). Independent of denoising approach, CN exhibited more segregated (clustering coefficient) but less integrated (largest component, path length, global efficiency) networks than MCI and AD. Independent of diagnosis, denoising strategy significantly affected the magnitude of all metrics, particularly models including global signal regression. Collectively, these results suggest that the directionality of the diagnostic differences in network topology, particularly in global metrics of network segregation, can vary based upon the denoising approach employed, although the effect size is small. Transparent reporting of preprocessing decisions is critical for the accurate interpretation of graph theoretical findings in the context of AD and a better understanding of the mechanisms underlying pathological aging.
(© 2026 The Author(s). Human Brain Mapping published by Wiley Periodicals LLC.)
References: PLoS One. 2012;7(3):e32766. (PMID: 22412922)
Neuroimage. 2007 Aug 1;37(1):90-101. (PMID: 17560126)
Ann Neurol. 2013 Dec;74(6):826-36. (PMID: 23536396)
PLoS One. 2012;7(3):e33540. (PMID: 22457774)
Nat Neurosci. 2017 Feb 23;20(3):365-377. (PMID: 28230847)
Brain Imaging Behav. 2016 Sep;10(3):799-817. (PMID: 26363784)
Neuroscience. 2021 Jan 1;452:192-207. (PMID: 33197505)
Alzheimers Dement. 2018 Apr;14(4):535-562. (PMID: 29653606)
Neurology. 2013 May 7;80(19):1778-83. (PMID: 23390181)
Brain Connect. 2013;3(4):339-52. (PMID: 23705677)
Neurobiol Aging. 2019 Mar;75:71-82. (PMID: 30553155)
Nature. 1998 Jun 4;393(6684):440-2. (PMID: 9623998)
Front Neuroinform. 2011 Aug 22;5:13. (PMID: 21897815)
Neuroimage. 2009 Feb 1;44(3):893-905. (PMID: 18976716)
J Neurosci. 2016 Nov 30;36(48):12083-12094. (PMID: 27903719)
Biol Psychiatry. 2013 Mar 1;73(5):472-81. (PMID: 22537793)
Neuroimage. 2017 Jul 1;154:174-187. (PMID: 28302591)
Front Aging Neurosci. 2020 Feb 19;12:28. (PMID: 32140102)
Brain. 2016 Feb;139(Pt 2):547-62. (PMID: 26586695)
Hum Brain Mapp. 2009 May;30(5):1511-23. (PMID: 18649353)
Neuroimage. 2012 Aug 15;62(2):911-22. (PMID: 22248580)
Ann Neurol. 2012 Oct;72(4):578-86. (PMID: 23109153)
Neurosci Bull. 2014 Apr;30(2):217-32. (PMID: 24733652)
Imaging Neurosci (Camb). 2025 Oct 31;3:. (PMID: 41190330)
Hum Brain Mapp. 2020 Jul;41(10):2629-2641. (PMID: 32087047)
Transl Psychiatry. 2021 Jan 18;11(1):61. (PMID: 33462184)
Nat Commun. 2024 Dec 12;15(1):10678. (PMID: 39668158)
Hum Brain Mapp. 2018 Nov;39(11):4213-4227. (PMID: 29962049)
IEEE Trans Med Imaging. 2001 Jan;20(1):45-57. (PMID: 11293691)
Brain Connect. 2016 Nov;6(9):700-713. (PMID: 27527561)
Nat Methods. 2019 Jan;16(1):111-116. (PMID: 30532080)
Brain Connect. 2012;2(1):25-32. (PMID: 22432927)
Neuroimage. 2017 Jul 1;154:128-149. (PMID: 27956209)
Neuroimage. 2021 May 1;231:117832. (PMID: 33549747)
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6798-807. (PMID: 26598686)
Neural Plast. 2020 Jun 29;2020:7839536. (PMID: 32684923)
Netw Neurosci. 2018 Oct 01;3(1):1-26. (PMID: 30793071)
PLoS One. 2008 Apr 30;3(4):e0002051. (PMID: 18446219)
J Neurosci. 2012 Jun 27;32(26):8890-9. (PMID: 22745490)
Neuroimage. 1999 Feb;9(2):179-94. (PMID: 9931268)
Neuroimage. 2017 Apr 15;150:213-229. (PMID: 28213118)
Brain. 2021 Aug 17;144(7):2176-2185. (PMID: 33725114)
BMC Bioinformatics. 2020 Nov 18;21(Suppl 6):123. (PMID: 33203351)
Neuroimage. 2017 Jul 1;154:169-173. (PMID: 27888059)
Neuroimage. 2018 May 1;171:415-436. (PMID: 29278773)
Psychiatry Res. 2012 May 31;202(2):118-25. (PMID: 22695315)
Comput Biomed Res. 1996 Jun;29(3):162-73. (PMID: 8812068)
Hum Brain Mapp. 2018 Nov;39(11):4545-4564. (PMID: 29999567)
Neuroimage. 2010 Sep;52(3):1059-69. (PMID: 19819337)
Neuroimage. 2014 Jan 1;84:320-41. (PMID: 23994314)
Neural Regen Res. 2019 Oct;14(10):1805-1813. (PMID: 31169199)
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20. (PMID: 20378467)
Neuroimage. 2002 Oct;17(2):825-41. (PMID: 12377157)
Front Neurosci. 2015 Feb 19;9:48. (PMID: 25745384)
Front Hum Neurosci. 2013 Dec 26;7:910. (PMID: 24421764)
Neuron. 2011 Nov 17;72(4):665-78. (PMID: 22099467)
PLoS One. 2010 Nov 01;5(11):e13788. (PMID: 21072180)
Brain Topogr. 2014 Nov;27(6):801-7. (PMID: 24599620)
Neuroimage. 2009 Oct 15;48(1):63-72. (PMID: 19573611)
Front Neurosci. 2020 Sep 30;14:558434. (PMID: 33100958)
Front Neurosci. 2020 Oct 15;14:575652. (PMID: 33177982)
Neuroimage. 2023 Apr 15;270:119972. (PMID: 36842522)
Neuropsychol Rev. 2003 Jun;13(2):79-92. (PMID: 12887040)
Med Image Anal. 2008 Feb;12(1):26-41. (PMID: 17659998)
Neurobiol Aging. 2014 Apr;35(4):757-68. (PMID: 24216223)
Front Hum Neurosci. 2019 Oct 17;13:369. (PMID: 31680919)
Nat Hum Behav. 2023 Aug;7(8):1344-1356. (PMID: 37365408)
Front Aging Neurosci. 2020 Oct 22;12:576627. (PMID: 33192468)
Neuroimage. 2013 Jan 1;64:240-56. (PMID: 22926292)
Eur J Neurosci. 2017 Nov;46(9):2471-2480. (PMID: 28922510)
Neural Regen Res. 2013 Oct 25;8(30):2789-99. (PMID: 25206600)
Front Neurol. 2019 Aug 30;10:904. (PMID: 31543860)
Neuroimage. 2015 May 15;112:267-277. (PMID: 25770991)
Nat Commun. 2024 Jun 4;15(1):4745. (PMID: 38834553)
Psychol Methods. 2003 Dec;8(4):434-47. (PMID: 14664681)
Front Hum Neurosci. 2013 Jul 12;7:356. (PMID: 23874279)
Neuroimage. 2012 Feb 1;59(3):2142-54. (PMID: 22019881)
Neuroimage. 2017 Feb 1;146:609-625. (PMID: 27751941)
Neuroimage. 2018 Feb 15;167:62-72. (PMID: 29155080)
J Neurophysiol. 2009 Jun;101(6):3270-83. (PMID: 19339462)
J Med Imaging (Bellingham). 2020 Jan;7(1):016002. (PMID: 32118092)
PLoS Comput Biol. 2008 Jun 27;4(6):e1000100. (PMID: 18584043)
Hum Brain Mapp. 2019 Jun 1;40(8):2358-2376. (PMID: 30666750)
J Neurosci Methods. 2017 Apr 15;282:69-80. (PMID: 28286064)
PLoS Comput Biol. 2010 Jun 10;6(6):e1000808. (PMID: 20548945)
Front Neurosci. 2015 Oct 27;9:395. (PMID: 26578859)
Magn Reson Med. 1996 Mar;35(3):346-55. (PMID: 8699946)
Phys Rev Lett. 2001 Nov 5;87(19):198701. (PMID: 11690461)
Alzheimers Dement. 2011 May;7(3):280-92. (PMID: 21514248)
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Jun;69(6 Pt 2):066133. (PMID: 15244693)
Cereb Cortex. 2014 Jun;24(6):1422-35. (PMID: 23314940)
Neuroimage. 2020 Jul 1;214:116756. (PMID: 32201326)
Grant Information: R01AG068990 United States NH NIH HHS; R01AG069265 United States NH NIH HHS; R01 AG068990 United States AG NIA NIH HHS; U01 AG024904 United States AG NIA NIH HHS; S10 OD025181 United States OD NIH HHS; R01 AG069265 United States AG NIA NIH HHS; S10OD025181 United States NH NIH HHS
Contributed Indexing: Keywords: Alzheimer's disease; denoising; fMRI; graph theory; nuisance regression; resting‐state
Entry Date(s): Date Created: 20260808 Date Completed: 20260808 Latest Revision: 20260826
Update Code: 20260826
PubMed Central ID: PMC13451523
DOI: 10.1002/hbm.70622
PMID: 42568124
Βάση Δεδομένων: MEDLINE